Prediction of Clinical Remission with Adalimumab Therapy in Patients with Ulcerative Colitis by Fourier Transform–Infrared Spectroscopy Coupled with Machine Learning Algorithms
We aimed to develop prediction models for clinical remission associated with adalimumab treatment in patients with ulcerative colitis (UC) using Fourier transform–infrared (FT–IR) spectroscopy coupled with machine learning (ML) algorithms. This prospective, observational, multicenter study enrolled...
Main Authors: | Seok-Young Kim, Seung Yong Shin, Maham Saeed, Ji Eun Ryu, Jung-Seop Kim, Junyoung Ahn, Youngmi Jung, Jung Min Moon, Chang Hwan Choi, Hyung-Kyoon Choi |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-12-01
|
Series: | Metabolites |
Subjects: | |
Online Access: | https://www.mdpi.com/2218-1989/14/1/2 |
Similar Items
-
Achievement of sustained deep remission with adalimumab in a patient with both refractory ulcerative colitis and seronegative erosive rheumatoid arthritis
by: G. Andrisani, et al.
Published: (2013-05-01) -
Bullous Pemphigoid Associated with Adalimumab Therapy in a Patient with Ulcerative Colitis
by: Sebastian Hoffmann, et al.
Published: (2018-05-01) -
Adalimumab-associated bullous pemphigoid in a patient with ulcerative colitis
by: Laurel L. Wessman, BS, et al.
Published: (2017-07-01) -
Comparison of long-term outcomes of infliximab and adalimumab therapy in biologic-naive patients with ulcerative colitis
by: Muhammed B. Durak, et al.
Published: (2025-01-01) -
Comparison of Long-Term Outcomes of Infliximab versus Adalimumab Treatment in Biologic-Naïve Patients with Ulcerative Colitis
by: Yong Il Lee, et al.
Published: (2021-03-01)